Search Results - "Pailhe, Aurelie"

Retreatment with sofosbuvir plus grazoprevir plus elbasvir plus ribavirin of patients with Hepatitis C virus Genotype 1 or 4 with RASs at failure of a sofosbuvir plus ledipasvir or plus daclatasvir or plus simeprevir regimen (ANRS HC34 REVENGE study) by Ledinghen, Victor De, Laforest, Claire, Hézode, Christophe, Pol, Stanislas, Renault, Alain, Alric, Laurent, Larrey, Dominique G, Metivier, Sophie, Tran, Albert, Jezequel, Caroline, Samuel, Didier, Zoulim, Fabien, Pailhe, Aurelie, Gibowski, Severine, Bourlière, Marc, Bellissant, Eric, Pawlotsky, Jean-Michel

“…67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) - Boston, MA - 2016-11-11…”
Get full text

Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study by de Lédinghen, Victor, Laforest, Claire, Hézode, Christophe, Pol, Stanislas, Renault, Alain, Alric, Laurent, Larrey, Dominique, Métivier, Sophie, Tran, Albert, Jézéquel, Caroline, Samuel, Didier, Zoulim, Fabien, Tual, Christelle, Pailhé, Aurélie, Gibowski, Séverine, Bourlière, Marc, Bellissant, Eric, Pawlotsky, Jean-Michel

“…Failure to achieve sustained virological response (SVR) with hepatitis C virus (HCV) direct-acting antiviral (DAA)-based regimens is commonly associated with…”
Get full text